NFKB1 and rheumatoid arthritis: PARP-1 regulates the activation of both transcription factors, and PARP inhibition or PARP-1 deficiency reduces the transcriptional activity of NF-κB and/or AP-1 in models of septic shock, inflammation, and ischemic-reperfusion, as well as in cancer and RA [51, 52, 57–59].